Antibiotic Market Overview by Shares and Future Outlook to 2019-2024

Antibiotic Market Share, Applications, Drivers and
Challenges to 2024
“Global Antibiotic Market includes In-depth Analysis
of industry by recent technologies, trends,
opportunities, challenges, key players and business
strategies considering types, segment, and future
analysis.”
7 February, 2019: The Global Antibiotic Market is expected to witness rapid growth in the near future due to the
development of novel products and rising investment in research & development of advanced antibiotic. Additionally,
development of thirty-seven highly advanced molecules in the U.S. region coupled with phase II clinical trials are
expected to foster market growth over the forecast period.
Favorable governmental regulation, reforms and legislations such as the Generating Antibiotics Incentives Now (GAIN)
Act are predicted to drive approval rate, thus propelling market growth further. Globally, the antibiotic market is
predicted to grow at a substantial CAGR in forecast period, providing numerous opportunities for market players to
invest in research and development in the antibiotic market.
Browse Full Research Report @ https://www.millioninsights.com/industry-reports/antibiotics-market
The Generating Antibiotics Incentives Now (GAIN) Act has enabled production of advanced set of therapies against
antibiotic resistant pathogens. These factors are expected to play a major role for the robust growth of market over the
forecast period. Growing demand of antibiotic drugs is attributed to rising prevalence of infectious diseases in both
developing and developed economies across the globe, in the recent years. Additionally, rising number of manufacturers

of antibiotic drugs and significant R&D activities in the market are expected to fuel market growth in the upcoming
years.
Infection diseases such as Diarrhea is considered as one of the Major cause of high mortality rate among children,
particularly in the developing and underdeveloped economies all around the globe. Increasing use of antibiotic drugs to
prevent this morbidity is anticipated to augment market demand over the forecast period. Increasing number of cases
related to other infectious diseases such as HIV, pneumonia, malaria, and tuberculosis is further propelling market
growth since last couple of decades.
Moreover, surfacing of unfamiliar infections, such as Zika virus and Ebola, has led to the soaring demand of antibiotics
in the market. Recent collaborations among various private bodies and research institute with governmental agencies
and colleges to develop innovative techniques and products to fight against unfamiliar infections, such as Zika virus and
Ebola is predicted to fuel market growth over the forecast period.
Rising funding from regional governments for innovative R&D approaches is leading to the generation of new pipeline
products. However, complexity associated with development of advanced antibiotics and high initial cost are some of
the major restraining factors for market growth to a certain extent. Additionally, lack of awareness of these products in
underdeveloped economies and the high cost of development of the drugs is anticipated to limit market growth.
Get a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/antibioticsmarket/request-sample
The monoclonal antibodies is considered as one of the fastest growing segment in the antibiotics market with substantial
revenue generation in the last couple of years. Other market segment along with monoclonal antibodies such as
tetracyclines, imidazoles and lincosamides hold massive market share across the globe.
Numerous benefits of monoclonal antibodies over its counter parts is considered as major driving factor for the growth
of monoclonal antibodies market segment. Growing prevalence of pneumonia, blood stream infections, and urinary tract
infections (UTI) are predicted to boost the demand of carbapenems class of antibiotics.
The antibiotics market is divided by region as North America, Europe, Asia-Pacific, Latin America and Africa. Latin
America has shown major growth in recent years owing to the rise in the implementation of latest technologies in
pharmaceuticals & medicine sector, strong economic growth in the region, and existence of well-established healthcare
infrastructure.
Asia-Pacific region is predicted to hold major market share in the antibiotics market with massive growth in forecast
period. Countries such as India, China and Japan are leading the Asia-Pacific’s market with increasing occurrence of
infectious diseases, ever-growing population in developing economies, favorable governmental regulation and reforms,
increasing use of generic medicines, and significant investment by leading industry players considering potential growth
opportunities in the region.
The key players in the antibiotics market are Pfizer Incorporations, Janssen Pharmaceuticals, Inc., Abbott Laboratories,
GlaxoSmithKline plc, Sanofi S.A., Novartis AG, Bayer AG, Bristol Myers Squibb Company, Eli Lilly and Company
Co., and Astellas Pharma Incorporations.

Market Segment:
The latest industry data included in the reports:
• Demand for antibiotics, 2011 - 2022
• Antibiotic market size by product type, 2011 - 2022
• Growth rates of the overall market and different product segments, 2011 - 2022
• Shares of different product segments of the overall market, 2011, 2017, and 2022
See More Reports of This Category by Million Insights @
https://www.millioninsights.com/industry/pharmaceuticals
The market data is given for the following product segments:
• Chloramphenicol
• Erythromycin
• Penicillins
• Streptomycins
• Tetracyclines
• Other antibiotics
• Medicaments containing penicillins
• Medicaments containing other antibiotics
Browse Full Research Report @ https://www.millioninsights.com/industry-reports/antibiotics-market

Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction.
Our representatives strive to understand diverse client requirements and cater to the same with the
most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: ryan@millioninsights.com
Global Headquarters
Million Insights
Felton Office Plaza 6265 Highway 9
Felton, California 95018, United States
Phone: 1-408-610-2300
Email: sales@millioninsights.com
Asia Pacific
Million Insights
Office No. 302, 3rd Floor, Manikchand
Galleria, Model Colony, Shivaji Nagar,
Pune, MH, 411016 India
Phone: 91-20-65300184
Email: sales@millioninsights.com
Visit Our Blog:
www.millioninsights.blogspot.com